See the DrugPatentWatch profile for ativan
Epilepsy cases can indeed lead to higher dosages of Ativan, but it's crucial to note that this should be determined by a healthcare professional. Ativan, also known as lorazepam, is a benzodiazepine medication often used to treat anxiety disorders, seizures, and insomnia [1].
In the context of epilepsy, Ativan can be used to manage status epilepticus, a serious condition characterized by prolonged or recurrent seizures [2]. Higher dosages may be required in these cases to control seizure activity. However, the decision to increase the dosage should be based on several factors, including the patient's weight, age, overall health, and response to treatment [3].
It's important to remember that while Ativan can be effective in treating epilepsy, it also carries a risk of side effects, such as drowsiness, dizziness, and weakness [1]. Higher dosages can increase the likelihood and severity of these side effects. Therefore, any changes to the dosage should be made under the close supervision of a healthcare provider.
In terms of drug patents, Ativan's patent expired in 2000 [4], which means that generic versions of the drug are available. This can make the medication more accessible and affordable for patients [5].
In summary, while epilepsy cases can necessitate higher Ativan dosages, this decision should be made by a healthcare professional, considering various factors to ensure the patient's safety and effectiveness of treatment.
Sources:
[1] "Lorazepam." MedlinePlus, U.S. National Library of Medicine, 15 Sept. 2021, medlineplus.gov/druginfo/meds/a682035.html.
[2] "Status Epilepticus." Mayo Clinic, Mayo Foundation for Medical Education and Research, 11 Feb. 2022, mayoclinic.org/diseases-conditions/status-epilepticus/symptoms-causes/syc-20355618.
[3] "Lorazepam (Oral Route) Side Effects." Mayo Clinic, Mayo Foundation for Medical Education and Research, 1 Jan. 2021, mayoclinic.org/drugs-supplements/lorazepam-oral-route/side-effects/drg-20063342?p=1.
[4] "Lorazepam (Ativan) Patent Expiration and Generic Entry." DrugPatentWatch, drugpatentwatch.com/drugs/lorazepam.
[5] "Generic Drugs: Questions and Answers." FDA, U.S. Food and Drug Administration, 15 Feb. 2022, fda.gov/drugs/understanding-generic-drugs/generic-drugs-questions-and-answers.